L2C leukemic cell suspensions consistently induce a generalized and fatal stem-cell leukemia, when inoculated subcutaneously or intraperitoneally into young, adult ‘strain 2’ or F1 hybrid guinea pigs. In experiments here reported ‘strain 2’ and F1 hybrid guinea pigs were inoculated by superficial skin scarification with small doses of diluted L2C leukemic cell suspensions. When about 40 to 50 days later such animals were reinoculated subcutaneously with massive doses (0.5 ml each) of leukemic cell suspensions of 10-2 concentration, 30 of 31 guinea pigs tested were found to be immune to the challenging inoculation. The same dose induced a generalized leukemia in all 45 untreated ‘strain 2’, and in 29 of 30 F1 untreated hybrid guinea pigs.

Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.